Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan
QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical... Read more.
MarketAxess to Participate in the Raymond James 2024 Institutional Investors Conference
NEW YORK–(BUSINESS WIRE)–MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities,... Read more.
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative... Read more.
Mainstay Medical Announces US$125 Million Equity Financing Transaction
Funding to accelerate commercial growth and expand clinical and health economic evidence for ReActiv8® Restorative Neuromodulation™ System DUBLIN–(BUSINESS... Read more.
Albany International Reports Fourth-Quarter 2023 Results
ROCHESTER, N.H.–(BUSINESS WIRE)–Albany International Corp. (NYSE:AIN) today reported operating results for its full year and fourth quarter of 2023,... Read more.
Bristol Myers Squibb to Participate in the TD Cowen 44th Annual Health Care Conference
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 44th Annual Health... Read more.
BGSF, Inc. Announces Timing of Fourth Quarter and Fiscal Year 2023 Results and Earnings Conference Call
PLANO, Texas–(BUSINESS WIRE)–BGSF, Inc. (NYSE: BGSF), a growing provider of consulting, managed services and workforce solutions, today announces that... Read more.
Genesco to Report Fourth Quarter Fiscal 2024 Results and Hold Conference Call on March 8, 2024
NASHVILLE, Tenn.–(BUSINESS WIRE)–Genesco Inc. (NYSE: GCO) today announced that the Company will report results for the fourth quarter fiscal 2024 on... Read more.
Two Harbors Investment Corp. to Present at the 2024 RBC Capital Markets Global Financial Institutions Conference
NEW YORK–(BUSINESS WIRE)–Two Harbors Investment Corp. (NYSE: TWO), an MSR + Agency RMBS real estate investment trust, today announced that President... Read more.
U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance
— Biktarvy Now First and Only INSTI-Based Single-Tablet Regimen That is FDA Approved and DHHS Guideline Recommended for People Who are Virologically Suppressed... Read more.